To determine whether common polymorphisms in the sweet taste receptor (TAS1R2) and glucose transporter (GLUT2) genes are associated with dental caries, 80 healthy Caucasian individuals aged 21–32 years were genotyped and grouped based on the TAS1R2 (Ile191Val) and GLUT2 (Thr110Ile) polymorphisms. Clinical and radiographic examinations were conducted by a single examiner who was blinded to the genotypes. To assess caries prevalence, three different caries scores were determined: DMFT (decayed, missing, and filled teeth), DMFT + X-ray and ICDAS (International Caries Detection and Assessment System). Associations between genotypes and caries prevalence were analyzed using Student’s t test. Based on the genotypes for each of the GLUT2 and TAS1R2 genes, individuals were stratified into four groups for comparison of caries scores. A higher DMFT score (mean ± SE; 4.3 ± 0.4 vs. 6.1 ± 1.2, p = 0.04) was observed among carriers of the Ile allele for GLUT2 (risk group). Carriers of the Val allele for TAS1R2 (resistant group) demonstrated lower caries scores: DMFT (4.1 ± 0.5 vs. 5.8 ± 0.9, p = 0.05), DMFT + X-ray (4.9 ± 0.6 vs. 7.5 ± 0.9, p = 0.01), and ICDAS (19.5 ± 2.2 vs. 26.14 ± 2.82, p = 0.03). Based on genotype stratification, caries scores were significantly lower in the double resistant group as compared to the double risk groups: DMFT (9.1 ± 0.08 vs. 4.2 ± 0.01, p < 0.01), DMFT + X-ray (10.5 ± 0.07 vs. 5.2 ± 0.01, p < 0.01) and ICDAS (32.9 ± 0.2 vs. 19.9 ± 0.01, p = 0.01). In conclusion, GLUT2 and TAS1R2 genotypes individually and in combination are associated with caries risk. Considering the combination of risk/resistance genotypes might further our understanding of genetic predispositions to dental caries and improve the accuracy of caries prediction models.

1.
Azevedo LF, Pecharki GD, Brancher JA, Cordeiro CA Jr, Medeiros KG, Antunes AA, Arruda ES, Werneck RI, de Azevedo LR, Mazur RF, Moysés SJ, Moysés ST, Faucz FR, Trevilatto PC: Analysis of the association between lactotransferrin (LTF) gene polymorphism and dental caries. J Appl Oral Sci 2010;18:166–170.
2.
Birch LL: Psychological influences on the childhood diet. J Nutr 1998;128(suppl 2):407S–410S.
3.
Boraas JC, Messer LB, Till MJ: A genetic contribution to dental caries, occlusion, and morphology as demonstrated by twins reared apart. J Dent Res 1988;67:1150–1155.
4.
Conry JP, Messer LB, Boraas JC, Aeppli DP, Bouchard TJ Jr: Dental caries and treatment characteristics in human twins reared apart. Arch Oral Biol 1993;38:937–943.
5.
Deeley K, Letra A, Rose EK, Brandon CA, Resick JM, Marazita ML, Vieira AR: Possible association of amelogenin to high caries experience in a Guatemalan-Mayan population. Caries Res 2008;42:8–13.
6.
Eny KM, Wolever TM, Corey PN, El-Sohemy A: Genetic variation in TAS1R2 (Ile191Val) is associated with consumption of sugars in overweight and obese individuals in 2 distinct populations. Am J Clin Nutr 2010;92:1501–1510.
7.
Eny KM, Wolever TM, Fontaine-Bisson B, El-Sohemy A: Genetic variant in the glucose transporter type 2 is associated with higher intakes of sugars in two distinct populations. Physiol Genomics 2008;33:355–360.
8.
Garcia-Bailo B, Toguri C, Eny KM, El-Sohemy A: Genetic variation in taste and its influence on food selection. OMICS 2009;13:69–80.
9.
Health Canada: Canadian guidelines for body weight classification in adults. 2005. www.hc-sc.gc.ca/fn-an/nutrition/weights-poids/guide-ld-adult/qa-qr-pub-eng.php.
10.
Hedge AM, Sharma A: Genetic sensitivity to 6-n-propylthiouracil (PROP) as a screening tool for obesity and dental caries in children. J Clin Pediatr Dent 2008;33:107–111.
11.
Kang S, Yoon I, Lee H, Cho J: Association between AMELX polymorphisms and dental caries in Koreans. Oral Dis 2010;17:399–406.
12.
Liem DG, de Graaf C: Sweet and sour preferences in young children and adults: role of repeated exposure. Physiol Behav 2004;83:421–429.
13.
Liem DG, Mennella JA: Sweet and sour preferences during childhood: role of early experiences. Dev Psychobiol 2002;41:388–395.
14.
Lin BP: Caries experience in children with various genetic sensitivity levels to the bitter taste of 6-n-propylthiouracil (PROP): a pilot study. Pediatr Dent 2003;25:37–42.
15.
Loe H, Silness J: Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand 1963;21:533–551.
16.
Mansbridge JN: Heredity and dental caries. J Dent Res 1959;38:337–347.
17.
McClain AD, Chappuis C, Nguyen-Rodriguez ST, Yaroch AL, Spruijt-Metz D: Psychosocial correlates of eating behavior in children and adolescents: a review. Int J Behav Nutr Phys Act 2009;6:54.
18.
Mennella JA, Jagnow CP, Beauchamp GK: Prenatal and postnatal flavor learning by human infants. Pediatrics 2001;107:E88.
19.
Mueckler M, Kruse M, Strube M, Riggs AC, Chiu KC, Permutt MA: A mutation in the GLUT2 glucose transporter gene of a diabetic patient abolishes transport activity. J Biol Chem 1994;269:17765–17767.
20.
Ozturk A, Famili P, Vieira AR: The antimicrobial peptide DEFB1 is associated with caries. J Dent Res 2010;89:631–636.
21.
Patir A, Seymen F, Yildirim M, Deeley K, Cooper ME, Marazita ML, Vieira AE: Enamel formation genes are associated with high caries experience in Turkish children. Caries Res 2008;42:394–400.
22.
Peres RC, Camargo G, Mofatto LS, Cortellazzi KL, Santos MC, Nobre-dos-Santos M, Bergamaschi CC, Line SR: Association of polymorphisms in the carbonic anhydrase 6 gene with salivary buffer capacity, dental plaque pH, and caries index in children aged 7–9 years. Pharmacogenomics J 2010;10:114–119.
23.
Rupesh S, Nayak UA: Genetic sensitivity to the bitter taste of 6-n propylthiouracil: a new risk determinant for dental caries in children. J Indian Soc Pedod Prev Dent 2006; 24:63–68.
24.
Shaffer JR, Feingold E, Wang X, Lee M, Tcuenco K, Weeks DE, Weyant RJ, Crout R, McNeil DW, Marazita ML: GWAS of dental caries patterns in the permanent dentition. J Dent Res 2012, E-pub ahead of print.
25.
Shaffer JR, Wang X, Feingold E, Lee M, Begum F, Weeks DE, Cuenco KT, Barmada MM, Wendell SK, Crosslin DR, Laurie CC, Doheny KF, Pugh EW, Zhang Q, Feenstra B, Geller F, Boyd HA, Zhang H, Melbye M, Murray JC, Weyant RJ, Crout R, McNeil DW, Levy SM, Slayton RL, Willing MC, Broffitt B, Vieira AR, Marazita ML: Genome-wide association scan for childhood caries implicates novel genes. J Dent Res 2011;90:1457–1462.
26.
Shuler CF: Inherited risks for susceptibility to dental caries. J Dent Educ 2001;65:1038–1045.
27.
Silness J, Loe H: Periodontal disease in pregnancy. II. correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964;22:121–135.
28.
Slayton RL, Cooper ME, Marazita ML: Tuftelin, mutans streptococci, and dental caries susceptibility. J Dent Res 2005;84:711–714.
29.
Tordoff MG, Alleva AM: Oral stimulation with aspartame increases hunger. Physiol Behav 1990;47:555–559.
30.
Wang X, Shaffer JR, Weyant RJ, Cuenco KT, DeSensi RS, Crout R, McNeil DW, Marazita ML: Genes and their effects on dental caries may differ between primary and permanent dentitions. Caries Res 2010;44:277–284.
31.
Wendell S, Wang X, Brown M, Cooper ME, DeSensi RS, Weyant RJ, Crout R, McNeil DW, Marazita ML: Taste genes associated with dental caries. J Dent Res 2010;89:1198–1202.
32.
Wurtman JJ, Wurtman RJ: Sucrose consumption early in life fails to modify the appetite of adult rats for sweet foods. Science 1979;205:321–322.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.